Get the Stockscreener App
62.79
0.59%
0.37
Centene Corp stock is traded at $62.79, with a volume of 4.42M.
It is up +0.59% in the last 24 hours and up +0.26% over the past month.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
See More
Previous Close:
$62.42
Open:
$62.4
24h Volume:
4.42M
Relative Volume:
0.92
Market Cap:
$29.94B
Revenue:
$163.07B
Net Income/Loss:
$3.31B
P/E Ratio:
10.06
EPS:
6.24
Net Cash Flow:
$-490.00M
1W Performance:
+4.37%
1M Performance:
+0.26%
6M Performance:
+4.39%
1Y Performance:
-19.14%
1-Day Range:
$62.03
$63.29
1-Week Range:
$59.05
$63.42
52-Week Range:
$55.03
$80.59
Centene Corp Stock (CNC) Company Profile
Name
Centene Corp
Sector
Industry
Phone
(314) 725-4477
Address
7700 FORSYTH BLVD., ST LOUIS
Compare CNC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
62.79 | 29.94B | 163.07B | 3.31B | -490.00M | 6.24 |
|
UNH
Unitedhealth Group Inc
|
380.64 | 364.02B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
404.58 | 92.63B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
333.46 | 89.43B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
66.97 | 85.34B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
249.53 | 31.20B | 117.76B | 1.21B | 2.39B | 9.95 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-08-25 | Upgrade | Jefferies | Underperform → Hold |
| Feb-06-25 | Downgrade | Argus | Buy → Hold |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Dec-13-24 | Upgrade | UBS | Neutral → Buy |
| Dec-10-24 | Downgrade | Jefferies | Hold → Underperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Mar-21-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-20-23 | Initiated | UBS | Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-30-22 | Initiated | Argus | Buy |
| Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-28-22 | Resumed | Barclays | Overweight |
| Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Resumed | Bernstein | Outperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-07-22 | Resumed | Barclays | Overweight |
| Jan-06-22 | Resumed | JP Morgan | Overweight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
| Dec-13-21 | Reiterated | BofA Securities | Buy |
| Dec-13-21 | Reiterated | Credit Suisse | Neutral |
| Dec-13-21 | Reiterated | Mizuho | Neutral |
| Dec-13-21 | Reiterated | Oppenheimer | Outperform |
| Dec-13-21 | Reiterated | Stephens | Overweight |
| Dec-13-21 | Reiterated | Truist | Buy |
| Dec-13-21 | Reiterated | Wells Fargo | Overweight |
| Dec-13-21 | Reiterated | Wolfe Research | Outperform |
| Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-19-21 | Initiated | Wells Fargo | Overweight |
| May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-10-21 | Initiated | Mizuho | Neutral |
| Jan-21-21 | Resumed | Goldman | Neutral |
| Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-03-20 | Resumed | Evercore ISI | Outperform |
| Jan-28-20 | Reiterated | Bernstein | Outperform |
| Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| May-10-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Jul-18-18 | Resumed | Citigroup | Neutral |
| Dec-18-17 | Reiterated | Jefferies | Buy |
| Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
| Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-17 | Reiterated | Barclays | Overweight |
| Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
| Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp Stock (CNC) Latest News
Centene Stock: Analyst Estimates & Ratings - Barchart.com
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
Centene Corporation (CNC) Reaffirms 2025 Earnings Guidance - GuruFocus
CENTENE SUBSIDIARY ARIZONA COMPLETE HEALTH JOINS SETTLEMENT AGREEMENT TO MOVE FORWARD WITH STATEWIDE LONG-TERM CARE MEDICAID CONTRACT - PR Newswire
Health Insurance Market Size to Lead USD 5,190 Bn by 2034 Rising chronic diseases and healthcare costs are fueling demand for coverage - GlobeNewswire Inc.
Oklahoma Complete Health Offers New and Upgraded Benefits for SoonerSelect Members in 2025 - Financial Times
New Strong Buy Stocks for May 1st - TradingView
Zacks.com featured highlights Centene, Pediatrix Medical, Pfizer, StoneCo and Banco Santander - Yahoo Finance
Centene Corporation (CNC): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential - Insider Monkey
Centene stock price target cut to $61 by Jefferies - Investing.com South Africa
Jefferies Adjusts Price Target for Centene (CNC), Maintains Hold Rating | CNC Stock News - GuruFocus
Centene (CNC) Sees Price Target Reduction by Barclays to $84 | C - GuruFocus
Centene Corporation (CNC): Among Billionaire Israel Englander’s Stock Picks with Huge Upside Potential - Insider Monkey
Forecasting The Future: 4 Analyst Projections For Centene - Benzinga
Centene (CNC) Price Target Reduced Amid Mixed Outlook | CNC Stoc - GuruFocus
Decoding Centene Corp (CNC): A Strategic SWOT Insight - GuruFocus
Centene Corp. stock underperforms Friday when compared to competitors - MSN
Centene Corporation (NYSE:CNC) Q1 2025 Earnings Call Transcript - Insider Monkey
Centene: Q1 Earnings Snapshot - CT Insider
Centene Corp (CNC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Wins ... - Yahoo Finance
Centene Corp (CNC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Wins ... By GuruFocus - Investing.com Canada
Centene Corp (CNC) Q1 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Centene, Molina Post Solid 1Q Earnings, but Investors Remain Skeptical - AIS Health
Centene (CNC) Shares Drop Amid Mixed Q1 2025 Results - GuruFocus
Why Centene (CNC) Shares Are Trading Lower Today - The Globe and Mail
Centene Q1 Earnings Beat Estimates On Marketplace Business Strength - Barchart.com
Centene stock falls on fear of Medicaid cuts, CEO sounds optimistic note - The Business Journals
Centene (CNC) Outperforms with Strong Q1 Revenue, Reaffirms 2025 Outlook | CNC Stock News - GuruFocus
Centene Q1 Earnings Beat Estimates on Marketplace Business Strength - Yahoo Finance
Unpacking claim DeSantis funneled Florida taxpayer money through his wife's charity - Snopes
Here's How Much You Would Have Made Owning Centene Stock In The Last 20 Years - Benzinga
Earnings call transcript: Centene beats Q1 2025 EPS forecast, stock drops - Investing.com
Centene (CNC) Adjusts Health Expenses Outlook Amid Strong Revenue Growth - GuruFocus
Centene Raises Revenue Guidance on Higher Health Plan Sales (CNC) - Bloomberg.com
Centene Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Insurer Centene Reaffirms Annual Profit Guidance, Reports Better Than Expected Q1 EarningsCentene (NYSE:CNC) - Benzinga
Part of the former Centene campus in University City will now be apartments - Charlotte Observer
Centene (CNC) Surpasses Q1 Earnings Expectations with Strong Gro - GuruFocus
Centene Corp (CNC) Q1 2025 Earnings: EPS of $2.90 Beats Estimate - GuruFocus
Centene’s (NYSE:CNC) Q1 Sales Beat Estimates, Guides For Strong Full-Year Sales - Barchart.com
Centene Corporation Reports First Quarter 2025 Results - TradingView
Centene Corporation Q1 Profit Increases, Beats Estimates - Nasdaq
CENTENE CORP SEC 10-Q Report - TradingView
CENTENE CORPORATION REPORTS FIRST QUARTER 2025 RESULTS - Yahoo Finance
Developer wins rezoning approval for Centene-owned land - Yahoo
Centene Corp Stock (CNC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):